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Abstract
The role of the human microbiome on cancer progression remains unclear. Therefore, in
this study, we investigated the influence of some quorum sensing peptides, produced by di-
verse commensal or pathogenic bacteria, on breast cancer cell invasion and thus cancer
outcome. Based on microscopy, transcriptome and Chick Chorioallantoic Membrane
(CAM) analyses, four peptides (PhrG from B. subtilis, CSP from S.mitis and EDF from
E. coli, together with its tripeptide analogue) were found to promote tumour cell invasion
and angiogenesis, thereby potentially influencing tumour metastasis. Our results offer not
only new insights on the possible role of the microbiome, but also further opportunities in
cancer prevention and therapy by competing with these endogenous molecules and/or by
modifying people’s life style.
Introduction
To date, cancer figures among the leading causes of death in human societies worldwide. Next
to a person’s genetic factors and carcinogens exposure, the human microbiome recently gath-
ered great attention in tumour development as well [1].Helicobacter pylori, a commensal of the
human stomach in almost half of the world’s population, was found to cause gastric adenocar-
cinoma through the CagA and VacA toxins [2]. Colon cancer on the other hand can be influ-
enced by several gut bacteria, producing reactive oxygen/nitrogen species or bacterial toxins
(e.g. Colibactin from Escherichia coli) [3, 4].
The vast majority of bacteria inhabit the human intestine, with as many as 1012 cells per
gram of the average human faeces. Besides, other habitats like skin, mouth, vagina and mam-
mary gland are occupied as well, next to the occasional presence in the blood (bacteraemia or
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septicaemia). The breast milk in the mammary gland is a continuous source of commensal,
mutualistic and potentially probiotic bacteria to the infant gut, containing i.a. lactic acid bacte-
ria, Staphylococcus and Streptococcus species [5]. In contrast to the breast milk, the human
breast tissue was originally thought to be sterile. However, given the nutrient rich fatty compo-
sition of the female breast, together with the blood and lymphatic vasculature, and the diffuse
location of the lobules and ducts, bacteria can spread within the mammary glands, resulting in
a breast tissue microbiome. Urbaniak et al. indeed found a higher abundance of Proteobacteria,
Firmicutes (specifically the class Bacilli) and Actinobacteria in the breast tissue, while no signs
or symptoms of infection were assigned [6]. These results, serving as a first indication, are ea-
gerly waiting to be confirmed and further investigated towards its pathophysiological role.
Bacteria communicate with each other by the use of signalling molecules in a cell-density
dependent manner, a process called ‘quorum sensing’. The signalling molecules differ between
the groups of bacteria: while Gram-negative bacteria predominantly use N-acyl homoserine
lacton (AHL) molecules, the Gram-positive bacteria communicate by the use of oligopeptides;
both Gram-positive and Gram-negative bacteria synthesize autoinducer-2 (AI-2) signalling
molecules. The quorum sensing process was found to be activated in vivo as both the quorum
sensing end products (e.g. biofilms or toxins) and signalling molecules were detected in differ-
ent areas of the human body. Bacterial biofilms that can be produced after quorum sensing
pathway activation can be detected at diverse physiological sites: e.g. dental plaques produced
by Streptococcus mitis or Lactobacillus species, as well as nosocomial infections with vascular
grafts or urinary catheters after biofilm formation by Staphylococci or Escherichia coli, were ob-
served [7]. Moreover, N-acyl homoserine lacton signalling molecules were detected in human
biological samples as well, including sputum, faeces and saliva [8, 9]. Although thus not yet in-
vestigated, it is very likely that also quorum sensing peptides are found in the human body, at
their site of origin or distributed throughout the human body via the blood circulation.
Despite the increasing evidence of the human microbiome influencing health, up till now,
no research has been performed describing the role of quorum sensing peptides on tumour
progression. However, important parallels are seen between the bacterial quorum sensing
mechanisms and the biochemical and biological mechanisms metastatic cancer cells use to
function as a society of malignant cancer cells. The process of biofilm formation has many of
the characteristics of metastatic colonization, including motility of cells towards appropriate
surfaces, attachment and interaction of cells with each other, surface adhesion and coloniza-
tion, formation of a complex, heterogeneity,. . . [10]. Seen these correlations, we hypothesized
that cancer cell behaviour can be influenced as well by the quorum sensing signalling peptides,
produced by the bacteria of the microbiome. The increasing incidence of breast cancer in
women in both developed and developing countries [11], together with the very recent identifi-
cation of different Gram-positive bacteria in the breast tissue [6], excited the research in the in-
fluence of quorum sensing peptides on breast cancer cell behaviour. To this end, we
investigated their effect on the human epithelial breast cancer cell line MCF-7/AZ, in order to
explain (part) of the microbiome-cancer relationship.
Materials and Methods
Cell culture
The epithelial breast adenocarcinoma cell line MCF-7/AZ (ATCC CCL-224) was grown in
high-glucose Dulbecco’s Modified Eagle’s Medium (DMEM), supplemented with 10% (V/V)
foetal bovine serum (FBS), 1% (w/V) L-glutamine, 100 U/ml penicillin and 100 μg/ml strepto-
mycin (all from Invitrogen/GIBCO, Gent, Belgium) in a humidified atmosphere of 10% CO2 at
37°C.
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Caco-2 cells, originating from a human colorectal carcinoma, were cultured in high-glucose
Dulbecco’s Modified Eagle’s Medium (DMEM) with L-glutamine, supplemented with 10% (V/
V) fetal bovine serum (FBS), 1% of nonessential amino acids (100x), 100 U/ml penicillin and
100 μg/ml streptomycin (all from Invitrogen/GIBCO, Gent, Belgium) in a humidified atmo-
sphere of 10% CO2 at 37°C.
Collagen type I invasion assay
Morphology changes of MCF-7/AZ cells were investigated using previously described methods
[12]. In brief, 10 000 cells were seeded per well in a 48-well plate, containing 150 μl of collagen
type I gel per well, thereby investigating cell morphology 24 hours post-treatment (Leica
DMI3000B phase contrast microscope). Peptide solutions (S1 Table) (> 80% purity; all from
GL Biochem, Shanghai, China) were prepared using ultrapure water and DMSO, obtaining
final peptide concentrations of 1 μM (maximum 0.05% DMSO), 100 nM and 10 nM after 1:10
dilution using growth medium. The placebo sample solely contained ultrapure water; the low
DMSO concentration did not influence cell behaviour. Two independent morphology ‘scor-
ings’ were obtained for each of the 3 replicates; peptides were found positive if collagen-
invasion or cell-stretching at minimum 2 consecutive concentrations was established. To
quantify these visual results, the number of cells containing invasive extensions were counted
and compared to the total number of cells in the field.
Human transcriptome array
Cells treated with either EDF, PhrG or CSP were analyzed in duplicate (independent treatment
and analysis) for whole transcriptome expression using Affymetrix GeneChip Human Tran-
scriptome Array 2.0. by AROS Applied Biotechnology A/S (Aarhus, Denmark); RNA expres-
sion was compared with placebo treated samples. Data analysis was performed using
Transcriptome Analysis Console (Affymetrix) and MetaCore (Thompson Reuters) software
programs. The microarray data are deposited at AROS Applied Biotechnology under project
numbers A2224 and A2080. The microarray data were submitted to ArrayExpress and received
accession number E-MTAB-3191.
Chick Chorioallantoic Membrane (CAM) assay
The Chick Chorioallantoic Membrane (CAM) assay was performed as described by Sys et al.:
6 days after (pre-treated, 100 nM) tumour cell transfer to the fertilized eggs, CAM was micro-
scopically scored and histologically examined after H&E staining [13]. For quantification of
microscopically observed neovascularisation, an average CAM score was calculated: the num-
ber of blood vessels in the 1 mm diameter ring around the 2 mm radius tumour centre was de-
termined [14]. Significant differences were evaluated using the Mann—Whitney U test.
Proteome assay
Protein expression was investigated using the Human XL Oncology Array kit (R&D Systems,
Abingdon, United Kingdom), following the instructions of the supplier. In brief, cell lysates
were obtained after 24 hours of incubation with PhrG (100 nM) or placebo (water) and 84 dif-
ferent proteins analysed in duplo using spotted capture antibodies, followed by incubation
with detection antibodies and chemiluminescent visualization. Membranes are finally exposed
to X-ray films for 1–10 minutes. The mean (blank corrected, n = 2) pixel density is calculated
using ImageJ software and compared with placebo treatment. Significant differences were eval-
uated using the independent samples t-test.
Quorum Sensing Peptides Influence Breast Cancer Cells
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Caco-2 permeability assay
For transport studies, Caco-2 cells were seeded at a density of 300 000 cells for each Transwell
(Corning Costar, New York, USA) membrane insert filter (0.4 μm pore size, 12 mm filter diam-
eter). Cell culture medium was changed every second day until monolayers were formed (day
21–29); monolayer integrity was evaluated using resistance measurements. Transport experi-
ments were performed in both the apical-to-basolateral and basolateral-to-apical direction in
Hanks’ balanced salt solution (HBSS), according to Hubatsch et al. [15]. Peptide solutions
(PhrG, EDF and EDF-analogue, each 10 μM in HBSS) were added to the donor compartment
and aliquots taken from the receiving solution after 30, 60, 90 and 120 minutes of incubation.
Aliquots of the donor solutions after 120 minutes were taken as well for calculation of the mass
balance. Atenolol (50 μM) and propranolol (20 μM) were used as the low- and high-permeabil-
ity control, respectively [16]. Peptide samples were analyzed using UPLC-ESI/MS in selected
ion monitoring (SIM, monoisotopic mass of the peptides) mode for the peptide analyte, with
limits of detection of 0.56–0.58 pmol/ml. The system consisted of a Waters Acquity H-Class
Bio-samples FTN (flow rate set at 0.5 ml/min), Waters Acquity H-Class BioQuaternary Solvent
Manager, Waters Acquity H-Class column module (set at 30°C) and Waters Xevo TQ-S,
equipped with Waters Empower Pro software version 2 and MassLynx version 4.1 (Waters,
Zellik, Belgium). Mixtures of water (0.1% formic acid m/V) and acetonitrile (0.1% formic acid
m/V) were used to create appropriate gradients (95% to 80% of water in 3 minutes) and
ACQUITY UPLC BEH300 C18 column (1.7 μm, 2.1 x 100 mm dimensions) for analysing the
peptide solutions (5 μl injection volume). PepT1 transport (apical-to-basolateral direction) was
investigated using the dipeptide LY (10 μM) substrate in combination with the quorum
sensing peptide.
The apparent permeability coefficient (Papp in cm/s) was determined from the amount of
compound transported per time and was calculated as follows (sink conditions): Papp = (dQ/
dt) / (A x C0), where dQ/dt is the steady-state flux (pmol/s), A is the surface area of the filter
(cm2) and C0 is the initial concentration of analyte in the donor chamber (pmol/ml).
Stability in cell medium and human plasma
In vitro chemical and metabolic stability was determined in cell medium and human plasma,
respectively, using previously described procedures [17]. In brief, 100 μg of peptide was incu-
bated in Krebs-Henseleit buffer pH 7.4 with cell medium/plasma (500 μl) at 37°C while shak-
ing. At predetermined time intervals (i.e. 0, 6 and 24 hours for cell medium; 0, 30 and 120
minutes for plasma), aliquots were immediately transferred into microtubes containing 1:1 vol-
ume of 1% (V/V) trifluoroacetic acid solution in water. The enzyme reaction was further
stopped by heating the solution at 95°C for 5 minutes. Next, the samples were centrifuged to
precipitate the denatured proteins and the supernatant analyzed using UPLC-PDA. Appropri-
ate placebo solutions were similarly prepared. Assuming first-order kinetics, the rate constant
k was obtained from ln(Pt/Pt0) = -kt, from which the half-life was determined as t1/2 = ln(2)/k.
Haemolysis assay
A 10 μM stock solution is prepared for each quorum sensing peptide using water, with or with-
out DMSO for solubility reasons. 40 μl of this stock solution is then diluted with 280 μl of 100
mM sodium phosphate buffer, pH 7.4 to obtain the peptide sample. To prepare the Red Blood
Cell (RBC) solution, freshly obtained human blood was centrifuged at 1500 rpm for 15 minutes
and the precipitate washed three times using freshly prepared 150 mMNaCl solution. After the
final centrifugation step, the precipitate was resuspended into 100 mM sodium phosphate buffer
pH 7.4 and mixed by inversion. The RBC solution was then diluted 1 to 10 with the same solvent
Quorum Sensing Peptides Influence Breast Cancer Cells
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to obtain the diluted RBC solution. To examine the haemolytic properties of the quorum sensing
peptides, 320 μl of the peptide sample was mixed with 80 μl of the diluted RBC solution to obtain
a final volume of 400 μl and a final peptide concentration of 1 μM. Samples were incubated for
1 hour at 37°C while gently shaking. 100 mM sodium phosphate buffer pH 7.4 and 1% (V/V)
Triton X-100 were chosen as the negative and positive control solutions, respectively. Blank so-
lution was obtained by mixing 40 μl of water or aqueous DMSO (60%) with 280 μl of 100 mM
sodium phosphate buffer pH 7.4 and 80 μl of diluted RBC solution. After 1 hour of incubation,
all samples were centrifuged at 20 000 g for 5 minutes. The absorbance of the supernatant was
measured at 405 nm and corrected for the blank absorbance. The percent haemolysis was then
calculated using the following equation: [(Asample—Ablank) / (Apositive control—Ablank)] × 100
Results
To investigate the crosstalk between the quorum sensing peptides produced by the host bacte-
ria and human breast cancer cells, we selected different signalling peptides from the Quorum-
peps database (S1 Table) [18]. Four quorum sensing peptides or analogues thereof were
consistently (and concentration-dependently) found to induce tumour cell invasion through a
type I collagen extracellular matrix: PhrG from Bacillus subtilis (EKMIG), a Competence Stim-
ulating Peptide (CSP) from Streptococcus mitis (EMRKSNNNFFHFLRRI) and Extracellular
Death Factor (EDF) from Escherichia coli (NNWNN), together with its analogue NWN
(Fig. 1). Other peptides (e.g. PhrA (ARNQT) from Bacillus subtilis or CSP (ESRLPKIRFD-
FIFPRKK) from Streptococcus mitis) did not induce invasive characteristics. These biologically
active peptides were found to be sufficiently stable in cell medium (Table 1), meaning that the
effects, observed after 24 hours of treatment, can be associated with the original peptide struc-
tures. These observations of invasive cellular extensions are linked to an induced epithelial-
to-mesenchymal transition (EMT), an important process in breast cancer progression and me-
tastasis and the primary cause of breast cancer-related deaths [19, 20].
Up-regulation of the Histone cluster 1 H4 gene (HIST1H4A-F/H-L) after EDF treatment,
which was observed by our transcriptome expression results (Table 2), assigns tumour progres-
sive characteristics to this quorum sensing peptide. Through its link with β-arrestin 1, EDF in-
duces angiogenesis, thereby promoting the survival of breast cancer cells. Moreover, it
promotes cytoskeleton reorganization of breast cancer cells as well through the cofilin pathway,
which is crucial for tumour migration [21–23]; these morphologic alterations were already ob-
served in our type I collagen invasion assay. With Notch1 over-expression, a poor clinical out-
come of breast cancer is correlated, again promoting angiogenesis and thus tumour
progression [24]. Over-expression of theMTRNR2L2 andMTRNR2L6 genes, leading to in-
creased synthesis of the Humanin-like proteins 2 and 6 respectively, can be linked to an anti-
apoptotic function of the EDF peptide [25]. Finally, up-regulation of EYA3-IT1 can be
associated with increased tumour size and metastasis, due to the tyrosine phosphatase activity
of the transcribed proteins, promoting the motility and invasiveness of cancer cells [26].
Gene expression 24 hours post-treatment, compared to placebo samples. Mean fold change
is calculated from duplicate samples (cut off:> 1.5 or< -1.5).
The angiogenic properties of the quorum sensing peptides, as postulated by the transcrip-
tome expression results, were confirmed using the Chick Chorioallantoic Membrane (CAM)
assay. From Fig. 2, it is clear that all investigated peptides significantly promoted neovasculari-
sation after peptide treatment of the tumour cells, compared to the placebo sample. This re-
cruitment of new blood vessels thereby contributes to the metastasis of tumour cells.
Histological evaluation of the membrane confirmed the invasive tumour cell properties
through the chorionic layer into the mesoderm, induced by the quorum sensing peptides
Quorum Sensing Peptides Influence Breast Cancer Cells
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Fig 1. Morphologic changes of non-invasive epithelial MCF-7/AZ cells, induced by quorum sensing peptides at 10 nM. (A) The invasive cellular
extensions, observed 24 hours post-treatment with PhrG (EKMIG), CSP (EMRKSNNNFFHFLRRI), EDF (NNWNN) and the EDF-analogue (NWN), indicate
tumour-promoting properties of these quorum sensing peptides. The placebo sample serves as the negative control and TGF-α (0.1 μg/ml) as the positive
control. (B) Mean (n = 3) number of cancer cells with induced morphology changes: a significant difference is observed between the PhrG peptide or EDF-
analogue and the placebo treatment (* p< 0.05, Mann-Whitney U test). Error bars represent SEM values.
doi:10.1371/journal.pone.0119471.g001
Quorum Sensing Peptides Influence Breast Cancer Cells
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(Fig. 3). Groups of chorionic epithelial cells thereby indicated an aggressive invasion of MCF-
7/AZ cells: the chorion is massively disrupted by the tumour cells, resulting in a collapse of the
membrane (black arrowheads in Fig. 3).
The results of quorum sensing peptide induced tumour cell invasion and angiogenesis were
confirmed by a protein expression assay (Fig. 4). An increase in Vascular Endothelial Growth
Factor (VEGF), Fibroblast Growth Factor (FGF) or Hepatocyte Growth Factor Receptor (c-
Met/HGFR), seen after quorum sensing peptide treatment, can be linked to the formation of
new blood vessels [27, 28]. Second, the induction of epithelial-to-mesenchymal transition
(EMT) of the cancer cells after peptide treatment is validated as well: both the Forkhead
box protein C2 (FOXC2) and Tyrosine-protein kinase (Axl) expression are significantly in-
duced [29, 30]; an increase in Vimentin expression, together with a decrease in E-cadherin are
associated with EMT as well, leading to tumour cell migration and cancer metastasis [31].
Moreover, a decrease in p53 protein expression can be linked to a reduced activation of
Table 1. In vitro cell medium half-life values of quorum sensing peptides.
Peptide Sequence Cell medium half-life (hours)
PhrG EKMIG 160a
CSP EMRKSNNNFFHFLRRI 45.84
EDF NNWNN 16.19
EDF-analogue NWN 42.03
The investigated quorum sensing peptides were found highly stable in cell medium.
a The calculated half-life is 157.89 hours
doi:10.1371/journal.pone.0119471.t001
Table 2. Transcriptome alterations after EDF, PhrG or CSP quorum sensing peptide addition to MCF-7/AZ cells.
Gene symbol Fold change ANOVA p-value Description
Upregulated
MIR548W 1.92 0.566 MicroRNA 548w
HIST1H4A-F/H-L 1.98 0.330 Histone cluster 1, H4(a-f/h-l)
MTRNR2L2 1.69 0.010 MT-RNR2-like 2
MTRNR2L6 1.58 0.243 MT-RNR2-like 6
RNU2–4P 1.59 0.011 RNA, U2 small nuclear 4, pseudogene
RNU4–4P 1.54 0.065 RNA, U4 small nuclear 4, pseudogene
MIR320C2 1.67 0.076 MicroRNA 320c-2
EYA3-IT1 1.75 0.087 EYA3 intronic transcript 1
IGLJ4 1.58 0.011 Immunoglobulin Lambda Joining 4
SNORD92 1.58 0.261 Small Nucleolar RNA, C/D Box 92
FOXP1-IT1 1.63 0.390 FOXP1 Intronic Transcript 1
MIR635 1.65 0.024 MicroRNA 635
Downregulated
RN5S217 -1.88 0.127 RNA, 5S ribosomal 217
FOXQ1 -1.72 0.338 Forkhead Box Q1
MAGEB5 -1.75 0.199 Melanoma Antigen Family B, 5
MIR4718 -1.64 0.401 MicroRNA 4718
LOC100128593 -1.56 0.084 Uncategorized LOC100128593
doi:10.1371/journal.pone.0119471.t002
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apoptosis, together with an increased activation of angiogenesis and tumour growth [32]. The
induced expression of C-Met/HGFR is associated with an increase of the tumour growth as
well [28].
Despite their possible presence in the human breast (cancer) tissue, we investigated the in-
testinal permeability characteristics of the quorum sensing peptides, produced by commensals
Fig 2. Neovascularisation after quorum sensing peptide treatment (100 nM) of MCF-7/AZ cells on
CAM. Placebo sample serves as negative control. (A) Macroscopic images, observed 6 days after (pre-
treated, 24 hours) tumour cell transfer to the eggs. (B) Mean CAM score (i.e. number of blood vessels in the 1
mm diameter ring around the 2 mm radius centre) in the presence of tumour cells (mean ± SEM, n = 5 (PhrG
and CSP), n = 3 (EDF) or n = 9 (placebo)). ** p< 0.05, * p< 0.1 (Mann-Whitney U test)
doi:10.1371/journal.pone.0119471.g002
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of the human gut, as well. Intestinal absorption of the peptides thereby strengthens the effects
observed on breast cancer cells. EDF (NNWNN), which is synthesized by the human gut com-
mensal Escherichia coli, was found to be impermeable through the human epithelial entero-
cytes under our experimental Caco-2 conditions (i.e. Papp< 2.9 × 10
-9 cm/s as LoD = 0.58
nM). However, its tripeptide analogue NWN shows low intestinal permeability kinetics
(Fig. 5): a permeability coefficient (Papp,ab) of 1.41 × 10
-7 cm/s was calculated for the apical-
to-basolateral transport. The efflux ratio (Papp,ba/Papp,ab) of 1.10 is doubled using the PepT1
substrate LY: the Papp,ab decreases to 6.94 × 10
-8 cm/s, indicative for the active proton-
dependent transport mechanism for peptide absorption. In vivo—in vitro correlation studies
demonstrated that these in vitro Papp values correspond with the absorption of about 5–10% in
humans (in vivo) [15, 33]. Quorum sensing peptide PhrG (EKMIG), produced by Bacillus sub-
tilis, only shows very small blood efflux (basolateral-to-apical) transport properties after
120 minutes (1.37 × 10-8 cm/s), without significant Caco-2 influx kinetics (LOD = 0.56 nM, so
Papp< 6.9 × 10
-9 cm/s).
Once the peptides have reached the blood circulation, they remain sufficiently stable
(Table 3), meaning that this pharmacokinetic property will not be the critical parameter for the
biological activity observed with these peptides. No haemolytic properties can be assigned to
the peptides (1 μM) as well (i.e. percentage of haemolysis< 1%), after a 1 hour
incubation period.
Fig 3. Histological H&E evaluation of the chorioallantoic membrane (CAM). Placebo sample serves as negative control. Tumour cells, when treated with
the quorum sensing peptides, moved through the chorionic layer into the mesoderm (orange arrowheads). Clusters of chorionic epithelial cells are indicated
by black arrowheads, indicating aggressive tumour cell invasion through the membrane.
doi:10.1371/journal.pone.0119471.g003
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Fig 4. Protein expression after PhrG quorum sensing peptide treatment (100 nM) of the MCF-7/AZ cells. Placebo sample serves as negative control.
Mean (n = 2, ± SEM) pixel density of some proteins are given after 24 hours of peptide incubation. * p< 0.05; ** p< 0.01; *** p< 0.001 (independent
samples t-test).
doi:10.1371/journal.pone.0119471.g004
Fig 5. Intestinal permeability of quorum sensing peptide NWN. (A) Mean (n = 5) apical-to-basolateral transport (i.e. intestinal absorption) of the EDF-
analogue (NWN) through a Caco-2 monolayer; (B) mean (n = 6) basolateral-to-apical transport (i.e. blood efflux) of the EDF analogue. Error bars represent
SEM values.
doi:10.1371/journal.pone.0119471.g005
Quorum Sensing Peptides Influence Breast Cancer Cells
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Discussion
Our in vitro results thus indicate that some quorum sensing peptides promote angiogenesis
and induce invasion of human breast cancer cells. Based on these results, different questions re-
lated to their biological relevance now arise: (1) Do these quorum sensing peptides reach the
breast cancer tissue, (2) Can we inhibit these negative microbiome-related effects, and (3) Does
this have consequences for the patient’s life style?
First, very recent investigations have shown that microbial DNA and viable bacterial cells
are present in healthy and cancerous breast tissue, thereby indicating that bacteria or their
components may influence the local microenvironment. The predominant bacteria in breast
tumours were Escherichia and Bacillus [34]. These findings elicit contradictions with previous
insights, where it was assumed that the breast tissue was a sterile location, except for the nipple
region; nipple duct contamination with skin flora is generally accepted and plays an important
role in breast infection [35]. Clearly, future studies are needed to confirm the presence of a
breast tissue microbiome under different personalised conditions and describe the different
bacterial species that are present. Next, a thorough exploration of the synthesized quorum
sensing peptides in the breast tissue should be performed as well; if found, they can negatively
influence the nearby breast cancer tissue.
Quorum sensing peptides, produced by commensal or pathogenic bacteria at distant loca-
tions, can reach the breast tissue as well via the blood circulation. N-acylhomoserine lacton
(AHL) molecules, another group of quorum sensing molecules, are already found in human
sputum, faeces and saliva, whereby the last biological sample reflects the systemic AHL concen-
tration [8, 36]. Besides, peptides that are synthesized in the gastrointestinal tract can pass the
intestinal barrier as well and consequently reach the blood circulation [37]. Our results indeed
indicate that the EDF-analogue NWN, with EDF being synthesized by the gut bacterium
E. coli, can pass the intestinal barrier, thereby reaching the blood circulation. The PhrG peptide
of Bacillus subtilis, also a gut bacterium, does not show any absorption from the intestinal
lumen. Intestinal permeability is however not limited to these small peptide structures: previ-
ous studies have indicated that larger peptides and proteins can also cross the normal intestine
in an intact form (e.g. insulin, β-casein) [38–40]. Moreover, the use of permeability enhancers
(e.g. bile salts, fatty acids or glycerides) can increase the intestinal absorption of the quorum
sensing peptides as well [41]. Quorum sensing peptides can also enter the circulation through
the skin or oral mucosa, seen the highly present bacterial population at these sites of the
human body [42] and the skin and mouth mucosa permeability-data already described for pep-
tides [43, 44]. In general, the oral mucosa is considered intermediately permeable, situated be-
tween the epidermis and the intestinal mucosa [45]. CSP, the quorum sensing peptide
synthesized by the oral commensal bacteria Streptococcus mitis, thus possibly can reach the
Table 3. In vitro plasma half-life values of quorum sensing peptides.
Peptide Sequence Plasma half-life (hours)
PhrG EKMIG >13a
CSP EMRKSNNNFFHFLRRI 8.73
EDF NNWNN >13a
EDF-analogue NWN 4.47
The investigated quorum sensing peptides were found sufﬁciently stable in human plasma, so tumour-promoting properties can be executed at the breast
cancer tissue.
a The calculated half-life is 13.16 hours
doi:10.1371/journal.pone.0119471.t003
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blood circulation after passing the oral mucosa; the same can be observed with the quorum
sensing peptide PhrG of Bacillus subtilis after passing the skin. This should however be investi-
gated by in vitro or in vivo permeability assays. Occasionally, bacteria themselves can also be
found in the blood circulation: Bacillus subtilis and Streptococcus mitis, commensals of the gas-
trointestinal tract or skin and oropharynx, respectively, were found to be present in the blood
of cancer patients [6, 46, 47]. PhrG and CSP, when present in the blood circulation, thus can af-
fect the clinical outcome of breast cancer, seen its pro-invasive characteristics on breast cancer
cells and angiogenesis-promoting properties. Although thus not yet confirmed, quorum sens-
ing peptides might be available from the blood and influence breast cancer progression.
To answer the second and third question, i.e. ‘Can we inhibit these microbiome-related ef-
fects and does this have consequences for the patient?’, the in vivo functionality of the quorum
sensing peptides should be investigated to confirm our obtained in vitro results. If the quorum
sensing peptides are found to be present in vivo, our preliminary in vitro findings of pro-
metastatic effects of quorum sensing peptides can open up new perspectives. First, after identi-
fication of the tumour target, quorum sensing peptide-based antagonists can be developed to
compete with these endogenous molecules for receptor binding. Tumour progression, induced
by the quorum sensing peptide, will then be blocked, indicating therapeutic properties for
these antagonists. Second, a person’s life style may be adapted to possibly influence the ob-
served bacteria-related effects. As a change in diet can drastically adapt the microbiota compo-
sition, and thus the quorum sensing peptide profile, this may possibly have consequences on
cancer outcome [48]. Last, inadequate hygienic measures during e.g. surgery can induce breast
infection as well. Moreover, during lactation, mastitis should be treated carefully to avoid un-
wanted bacterial infection of the breast tissue as well [49].
The results of this study thus indicate the existence of a crosstalk system between bacteria
and breast cancer cells through quorum sensing peptides. More specifically, we showed that
these quorum sensing peptides promote breast cancer cell invasion and angiogenesis, and thus
that bacteria can potentially influence tumour metastasis. Further research concerning their bi-
ological availability should be performed to strengthen these functionality results.
Supporting Information
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